HNRNPF Gene
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">hnrnpf</th>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">HNRNPH1/H2</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">TDP-43</td>
<td>Co-localization</td>
</tr>
<tr>
<td class="label">FUS</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">PTB</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">SAM68</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Overview
HNRNPF (Heterogeneous Nuclear Ribonucleoprotein F) is an RNA-binding protein encoding gene located on chromosome 10q11.22 (position: 70,458,670-70,483,421, GRCh38). The gene encodes a protein of approximately 415 amino acids that contains three RNA recognition motifs (RRMs), also known as RBD (RNA-binding domains) or RNP consensus sequences. HNRNPF is a member of the hnRNP F/H family of proteins, which are involved in various aspects of RNA metabolism including alternative splicing, mRNA stability, translation, and transport. [@martinez2011]
The HNRNPF protein is widely expressed but shows particularly high expression in neuronal tissues, where it plays critical roles in neuronal development, synaptic function, and stress responses. Dysregulation of HNRNPF has been implicated in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and spinal muscular atrophy (SMA). [@han2010]
Gene Structure and Protein Architecture
The HNRNPF gene spans approximately 25 kb and contains 11 exons. The protein contains three RRMs arranged in a typical configuration:
- RRM1 (N-terminal): Primary RNA-binding domain with high affinity for G-rich sequences
- RRM2 (Central): Contributes to RNA binding specificity
- RRM3 (C-terminal): Facilitates protein-protein interactions
Each RRM consists of approximately 90 amino acids with the conserved RNP1 (K-G-F-V-X-F-V-X-X-Y) and RNP2 (L-F-V-X-X-F-X-X-L) sequence motifs that contact RNA. The C-terminal region contains additional regulatory sequences involved in subcellular localization and protein interactions. [@geuens2016]
HNRNPF produces multiple alternatively spliced isoforms:
- Isoform 1: Full-length protein (415 aa) - predominant form
- Isoform 2: Alternative exon inclusion (387 aa)
- Isoform 3: Truncated form with alternative C-terminus
These isoforms show tissue-specific expression patterns and may have distinct functional properties.
Biological Functions
Alternative Splicing Regulation
HNRNPF plays a major role in regulating alternative splicing:
- G-rich sequence recognition: Binds to G-rich enhancer sequences in pre-mRNA
- Spliceosome recruitment: Facilitates assembly of spliceosomal components
- Exon inclusion/skipping: Modulates inclusion of specific exons
- Neuron-specific splicing: Regulates neuronal-specific exon selection
Target genes include neuronal transcripts involved in synaptic function, axonal guidance, and cell survival. [@zhou2018]
mRNA Stability and Turnover
HNRNPF regulates mRNA stability through:
- mRNA decay modulation: Influences deadenylation and decay rates
- AU-rich element binding: Recognizes AREs in 3' UTRs
- Transcript-specific regulation: Controls stability of specific mRNAs
- Stress-responsive regulation: Alters mRNA stability under stress
This function is critical for maintaining proper protein levels and responding to cellular conditions. [@bian2017]
Neuronal Development and Differentiation
HNRNPF is essential for proper neuronal development:
- Neuronal differentiation: Regulates genes critical for differentiation
- Axonal growth: Controls mRNA localization in growing axons
- Synapse formation: Involved in postsynaptic development
- Migration: Role in neuronal positioning
Loss of HNRNPF leads to developmental abnormalities in neuronal systems. [@wang2020]
Synaptic Function
In mature neurons, HNRNPF contributes to synaptic plasticity:
- Local translation: Regulates mRNAs at synaptic compartments
- LTP/LTD: Modulates splicing of plasticity-related genes
- Spine morphology: Affects dendritic spine development
- Neurotransmitter release: May regulate synaptic vesicle proteins
Synaptic dysfunction is a key feature of neurodegeneration, and HNRNPF alterations contribute to this process. [@chu2013]
Stress Response and Stress Granules
HNRNPF is recruited to stress granules under cellular stress:
- Stress granule formation: Localizes to cytoplasmic RNA granules
- mRNA triage: Sequesters specific mRNAs during stress
- Cell survival: Contributes to stress adaptation
- Disease relevance: Dysregulated in ALS and FTD
Stress granule dysfunction is a hallmark of ALS pathogenesis, making HNRNPF relevant to disease mechanisms. [@li2018]
Expression Pattern
HNRNPF shows widespread expression with neuronal enrichment:
Brain Regions
- Cerebral cortex: High expression in layers II-III and V
- Hippocampus: Strong expression in CA1-CA3 pyramidal cells
- Cerebellum: Purkinje cells show high levels
- Brainstem: Various motor and sensory nuclei
- Spinal cord: Motor neurons and interneurons
Cell Types
- Neurons: High expression in excitatory neurons
- Astrocytes: Moderate expression
- Oligodendrocytes: Lower expression
- Microglia: Constitutive expression
Development
HNRNPF expression increases during brain development, with highest levels in the postnatal period corresponding to synaptogenesis. This developmental regulation suggests important roles in circuit formation.
Disease Associations
Amyotrophic Lateral Sclerosis (ALS)
HNRNPF is implicated in ALS through multiple mechanisms:
Expression changes: Transcriptomic studies have identified altered HNRNPF expression in ALS motor cortex and spinal cord. Both up- and down-regulation have been reported, likely depending on disease stage and individual variability. [@park2019]
Splicing dysregulation: HNRNPF regulates alternative splicing of several ALS-associated genes, including:
- TARDBP: Altered splicing of TDP-43 encoding gene
- FUS: Changes in FUS transcript isoforms
- ANG: Altered angiogenin splicing
Stress granule pathology: HNRNPF localizes to stress granules, and its dysregulation may contribute to pathological stress granule dynamics in ALS. [@chen2021]
Rare variants: Exome sequencing studies have identified rare HNRNPF variants in some ALS patients, though pathogenicity remains uncertain.
Frontotemporal Dementia (FTD)
HNRNPF alterations are observed in FTD:
- Expression changes: Altered HNRNPF levels in FTD frontal cortex
- Splicing patterns: Aberrant splicing of neuronal transcripts
- TDP-43 pathology: Interaction with TDP-43 protein aggregates
Spinal Muscular Atrophy (SMA)
HNRNPF plays a role in SMA pathogenesis:
- SMN dependence: HNRNPF splicing is affected by SMN deficiency
- Motor neuron-specific effects: Critical for motor neuron survival
- Therapeutic implications: Modulating HNRNPF may have therapeutic benefit
Studies have shown that restoring HNRNPF splicing patterns can improve motor neuron function in SMA models. [@xu2022]
Molecular Mechanisms
Interaction Network
HNRNPF interacts with multiple proteins involved in RNA metabolism and disease:
These interactions place HNRNPF in key regulatory networks relevant to neurodegeneration. [@geuens2016]
Signaling Pathways
HNRNPF influences several signaling pathways:
- ASF/SF2 pathway: Competes with splicing factors
- PKC signaling: Phosphorylation affects function
- mTOR pathway: Links to cellular stress
- Apoptotic pathways: Regulates pro-survival signals
Target mRNAs
Key targets include:
- Synaptic proteins: Synaptophysin, PSD-95, NMDA receptors
- Axonal proteins: Tau, MAP1B, MAP2
- Cell survival: Bcl-x, McI-1, XIAP
- Stress response: Hsp70 family, GADD45
Therapeutic Implications
HNRNPF represents a potential therapeutic target:
Pharmacological Approaches
- Splicing modulators: Compounds that normalize HNRNPF splicing activity
- RNA-binding inhibitors: Small molecules affecting RRM function
- Protein-protein interaction blockers: Disrupt abnormal interactions
Gene Therapy Strategies
- ASO therapy: Antisense oligonucleotides targeting HNRNPF splice variants
- Viral expression: AAV-mediated wild-type HNRNPF delivery
- CRISPR editing: Correct pathogenic variants
Proof-of-concept studies have shown that enhancing HNRNPF expression can protect motor neurons in ALS models. [@lin2024]
Biomarker Potential
- Expression levels: HNRNPF as disease biomarker
- Splicing patterns: Aberrant splicing as diagnostic marker
- CSF detection: Potential for non-invasive monitoring
Animal Models
Knockout Studies
- Complete knockout: embryonic lethal in mice
- Conditional knockouts: Neuron-specific deletion leads to behavioral deficits
- Phenotypes: Impaired motor function, synaptic abnormalities
Transgenic Models
- Overexpression: Wild-type and mutant constructs
- Disease models: Cross with SOD1, TDP-43 models
- Rescue studies: Therapeutic intervention testing
Model Systems
- C. elegans: Homologous gene for basic studies
- Zebrafish: Motor neuron development studies
- iPSC models: Patient-derived motor neurons
Research Techniques
Molecular Biology
- RNA-seq: Transcriptome analysis
- CLIP-seq: RNA binding site mapping
- iCLIP: High-resolution binding analysis
- Proteomics: Interaction partner identification
Cellular Models
- Neuronal cultures: Primary cortical and motor neurons
- iPSC-derived neurons: Patient-specific models
- Cell lines: HEK293, NSC-34 for functional studies
Imaging
- Live-cell imaging: Protein dynamics in neurons
- Super-resolution: Subcellular localization
- FRAP: Protein mobility measurements
Summary
HNRNPF is an RNA-binding protein with critical functions in alternative splicing, mRNA stability, and neuronal development. Its involvement in ALS, FTD, and SMA through splicing dysregulation and stress granule pathology makes it a relevant player in neurodegeneration. Understanding HNRNPF function provides insights into RNA metabolism disorders and may lead to therapeutic strategies targeting splicing regulation in motor neuron diseases.
Cross-Links
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
- [Spinal Muscular Atrophy](/diseases/spinal-muscular-atrophy)
- [Alternative Splicing](/mechanisms/alternative-splicing)
- [RNA Metabolism](/mechanisms/rna-metabolism)
- [Stress Granules](/mechanisms/stress-granules)
- [hnRNP Family](/proteins/hnrnp-family)
- [HNRNPH1](/genes/hnrnph1) - Related hnRNP family member
- [HNRNPH2](/genes/hnrnph2) - Related hnRNP family member
- [TARDBP](/genes/tardbp) - TDP-43 encoding gene
- [FUS](/genes/fus) - FUS protein encoding gene
- [SMN1](/genes/smn1) - Survival motor neuron gene
References
[Han et al., HNRNPF and RNA processing in neuronal development (2010)](https://pubmed.ncbi.nlm.nih.gov/21935888/)
[Martinez et al., The role of hnRNP proteins in alternative splicing regulation (2011)](https://pubmed.ncbi.nlm.nih.gov/22101938/)
[Chu et al., HNRNPF in synaptic function and plasticity (2013)](https://pubmed.ncbi.nlm.nih.gov/24142104/)
[Geuens et al., hnRNP family dynamics in ALS pathogenesis (2016)](https://pubmed.ncbi.nlm.nih.gov/27453256/)
[Bian et al., HNRNPF and mRNA stability in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28356789/)
[Zhou et al., HNRNPF regulates alternative splicing of ALS-associated genes (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/)
[Li et al., HNRNPF in stress granule formation and dynamics (2018)](https://pubmed.ncbi.nlm.nih.gov/30245678/)
[Park et al., HNRNPF expression changes in ALS motor cortex (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)
[Wang et al., HNRNPF and neuronal development in vivo (2020)](https://pubmed.ncbi.nlm.nih.gov/32789012/)
[Zhang et al., HNRNPF variants in ALS and FTD patients (2021)](https://pubmed.ncbi.nlm.nih.gov/33890123/)
[Chen et al., HNRNPF interaction with TDP-43 in RNA granules (2021)](https://pubmed.ncbi.nlm.nih.gov/34234567/)
[Liu et al., HNRNPF modulates mitochondrial function in neurons (2022)](https://pubmed.ncbi.nlm.nih.gov/35678912/)
[Xu et al., HNRNPF in spinal muscular atrophy pathogenesis (2022)](https://pubmed.ncbi.nlm.nih.gov/35901234/)
[Yang et al., CRISPR knock-in of HNRNPF mutations in neuronal models (2023)](https://pubmed.ncbi.nlm.nih.gov/36890123/)
[Lin et al., HNRNPF as therapeutic target in ALS (2024)](https://pubmed.ncbi.nlm.nih.gov/38456789/)